| Di Lorenzo G, Autorino R, Sternberg CN
Metastatic Renal Cell Carcinoma: Recent Advances in the Targeted Therapy Era. [JOURNAL ARTICLE]
Eur Urol 2009 Sep 8.
Abstract | Full Citation | Find Related Articles |
| Cersosimo RJ
Renal cell carcinoma with an emphasis on drug therapy of advanced disease, part 2. [Journal Article]
Am J Health Syst Pharm 2009 Sep 15; 66(18):1625-33.
Abstract | Full Citation | Publisher Full Text | Find Related Articles |
| Ruan J, Coleman M, Leonard JP
Management of relapsed mantle cell lymphoma: still a treatment challenge. [Journal Article]
Oncology (Williston Park) 2009 Jul; 23(8):683-90.
Abstract | Full Citation | Find Related Articles |
| Cersosimo RJ
Renal cell carcinoma with an emphasis on drug therapy of advanced disease, part 1. [Journal Article]
Am J Health Syst Pharm 2009 Sep 1; 66(17):1525-36.
Abstract | Full Citation | Publisher Full Text | Find Related Articles |
| Fung AS, Wu L, Tannock IF
Concurrent and Sequential Administration of Chemotherapy and the Mammalian Target of Rapamycin Inhibitor Temsirolimus in Human Cancer Cells and Xenografts. [JOURNAL ARTICLE]
Clin Cancer Res 2009 Aug 25.
Abstract | Full Citation |
| Liu D, Hou P, Liu Z, et al.
Genetic alterations in the phosphoinositide 3-kinase/Akt signaling pathway confer sensitivity of thyroid cancer cells to therapeutic targeting of Akt and mammalian target of rapamycin. [Journal Article, Research Support, N.I.H., Extramural]
Cancer Res 2009 Sep 15; 69(18):7311-9.
Abstract | Full Citation | Publisher Full Text | Find Related Articles |
| Hickerson RP, Leake D, Pho LN, et al.
Rapamycin selectively inhibits expression of an inducible keratin (K6a) in human keratinocytes and improves symptoms in pachyonychia congenita patients. [JOURNAL ARTICLE]
J Dermatol Sci 2009 Aug 20.
Abstract | Full Citation | Find Related Articles |
| Xia JS, Chen XG, Zhuang QY, et al.
[The mTOR inhibitor enhances chemosensitivity of androgen-independent prostate cancer cell line] [English Abstract, Journal Article]
Zhonghua Nan Ke Xue 2009 Jul; 15(7):617-20.
Abstract | Full Citation | Find Related Articles |
| Clement JM, McDermott DF
The High-Dose Aldesleukin (IL-2) "Select" Trial: A Trial Designed to Prospectively Validate Predictive Models of Response to High-Dose IL-2 Treatment in Patients With Metastatic Renal Cell Carcinoma. [JOURNAL ARTICLE]
Clin Genitourin Cancer 2009 Aug 1; 7(2):E7-E9.
Abstract | Full Citation | Find Related Articles |
| Gandhi M, Kuzel T, Lacouture M
Eosinophilic Rash Secondary to Temsirolimus. [JOURNAL ARTICLE]
Clin Genitourin Cancer 2009 Aug 1; 7(2):E34-E36.
Abstract | Full Citation |
   |
